Asensus Surgical wants to incorporate artificial intelligence in its surgical robotic platforms and has partnered with Nvidia. Fast Five hosts Sean Whooley and Danielle Kirsh explain the goal of the partnership and how Asensus plans to use Nvidia's tools.

Align Technology this week launched its Invisalign palatal expanders. Find out what features are included in the palatal expanders and how they differ from gold standard methods. 

Inogen's CFO is stepping away from the company and the company named an interim replacement. Tune in to hear who is taking that interim spot and their career background. 

Boston Scientific's series of positive news continues this week with the FDA approval of its next-gen Watchman FLX Pro. Whooley describes what the Watchman FLX Pro does and the prevalence use in previous iterations of the device. 

Philips has announced that it reached a settlement in the class-action lawsuit stemming from its Respironics sleep apnea machine recalls. Hear what the agreement resolves and what the financial details of the settlement are. 

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Admetsys this week won FDA breakthrough designation for its automated glucose control technology. Fast Five hosts Sean Whooley and Danielle Kirsh discuss what the glucose control system does and what executives are saying.

Moximed has implanted its first Misha knee implantable shock absorber in the U.S. Find out what an implantable shock absorber is and what doctors think about it. 

GE HealthCare and Mass General are collaborating on AI algorithms to predict missed care opportunities, expanding on its existing 10-year partnership. Whooley explains the aim of the collaboration and what the artificial intelligence algorithms will be used for. 

Zimmer Biomet announced several executive appointments just days after former CEO Bryan Hanson left. Tune in to discover who joins the executive team and what the new CEO says about the shuffling. 

Another diabetes acquisition is in the news – this time, Abbott is acquiring Bigfoot Biomedical. The acquisition follows an established partnership between the companies. Whooley explains their prior partnership and other acquisition news in the diabetes sector.

Check out the show notes for links to the stories we discussed at MassDevice.com/podcast.

Axogen this week announced it launched its AxoGuard HA+ nerve protector. Fast Five hosts Sean Whooley and Danielle Kirsh share details on what AxoGuard is and why it is essential from a doctor's perspective.

The surgical robotics space is expanding. Ronovo Surgical announced it raised $26 million in capital for its surgical robotic platform. Whooley explains what the surgical robot is designed for, what it gives surgeons and what Ronovo Surgical plans to do with the raised capital.

Restor3d's acquisition of Conformis is finalized. Kirsh and Whooley discuss some of the deal's financial details and what executives think about the value-add. 

Another trending space in medtech is brain-computer interfaces. Synchron announced this week that it completed patient enrollment in its new BCI trial. Find out the details of the trial, including the study's primary goal, and who are some of the other major players in the BCI space.

Illumina has appointed a new CEO amid its SEC investigation. Whooley reveals who is taking over the corner office, some of their career history, and the challenges for the new CEO.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Glucotrack is back in this news, this time with news of a former Medtronic veteran being tapped for its board director spot. Fast Five hosts Sean Whooley and Danielle Kirsh go over the new appointee and their career history.

Zeiss Medical Technology this week announced it intends to unveil new ophthalmic innovations within its cataract and corneal refractive workflows. Find out what updates the company is planning to make and what executives are thinking.

LivaNova has received FDA 510(k) clearance for its Essenz in-line blood monitor. Whooley talks about what the blood monitor does, how it helps patients and why this is an important innovation. 

Beta Bionics closed a $100 million Series D funding round for its bionic pancreas. Tune in to discover what a bionic pancreas does and how optimistic executives are after this funding round.

The field of surgical robotics is constantly innovating. Noah Medical this week announced positive first-in-human data for its own surgical robot. Learn more about the company's surgical robot, what the data said and how doctors feel about using the technology.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Aion Biosystems announced this week that it won FDA 510(k) clearance for its iTempShield device and software system. Fast Five hosts Sean Whooley and Danielle Kirsh discuss what the system is, how it works and what executives are saying about the FDA clearance.

Over-the-counter Narcan just became available with Emergent BioSolutions' recent launch. Find out about the company's FDA approval to get to this point and how it will become available to consumers. 

Myomo has closed a $4.4 million public offering. In today's episode, Whooley details the offering and what the company plans to use proceeds for, including potentially expanding its employee count.

Cardinal Health has launched its next-generation neonatal feeding device to reduce NICU stays. Discover how the system works, how it helps clinicians and what executives are saying about the launch.

The legal proceeding with 3M and its combat earplugs has reached a $6 billion settlement. Whooley and Kirsh go over the breakdown of the payments like how it plans to pay and how the agreement was structured for the settlement. 

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Implantable continuous glucose maker Glucotrack announced it has a new VP of marketing. Fast Five hosts Sean Whooley and Danielle Kirsh talk about the new VP and their career history that supports the appointment.

Haemonetics is expanding its global presence by launching its vascular closure device in Europe. Find out which device is going global, how it works and what's next for Haemonetics.

The FDA granted 510(k) clearance to ICU Medical's infusion pump and software. Whooley explains what the they do and some of the features that make patient monitoring seamless.

Pediatric devices is an underserved market, and PolyVascular and CobiCure are looking to fix that with a new partnership for non-surgical pediatric heart valves. Hear more about the partnership and what kinds of resources and funding the companies have.

Biotronik has implanted its next-gen pacemaker in its first patients. Whooley details what the Anmia Edge is designed for, what benefits it offers and what doctors think about the device.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

SmileDirectClub and Align Technology are in a legal proceeding from a previous partnership. Fast Five hosts Sean Whooley and Danielle Kirsh discuss SDC's plans to appeal a court order that said it has to pay Align Technology $63 million. In today's episode, find out more about the proceeding and the SmileDirectClub's appeal.

GE Healthcare has unveiled its latest wireless, handheld ultrasound device. Whooley explains what the device does, how accompanying digital tools help clinicians and what executives think about this unveiling. 

Diabetes news and continuous glucose monitors continue to innovate. This week, Insulet launched its Omnipod 5 in Germany and announced when it expects a full European launch. Whooley outlines the regulatory pathway Omnipod 5 took to get to the Germany launch and how patients and executives feel about its entry into Europe.

This week, we have study data from the European Society of Cardiology (ESC) in Amsterdam. Medtronic posted study results that demonstrated ICDs could prevent sudden cardiac death. Hear some of the data points from the study.

Boston Scientific also posted results from ESC. Its Farapulse pulsed-field ablation device had positive results – and analysts now expect FDA approval and rapid adoption on the U.S. market. Listen to today's episode for more details.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

This week, the FDA granted a fast-track designation for Nectero Medical's end-vascular aneurysm stabilization treatment system. Fast Five hosts Sean Whooley and Danielle Kirsh explain how the system works and what executives say about this FDA win.

There's more AFib news on the horizon, this time from GE Healthcare. The company launched its CardioVisio digital tool for helping to treat AFib. Find out what the system does and the ultimate goal for GE Healthcare.

SPAC mergers are back in the news as Sanuwave Health plans to go public after a business combination agreement with SEP Acquisition Corp. The proposed transaction is valued at $127.5 million. Hear more about the financial details of the deal and the optimism that executives have.

Long-term organ preservation is important for organ transplants. Paragonix's next-generation BAROguard donor lung preservation system won FDA clearance this week. Whooley explains how the system works and what differentiates it from gold-standard organ transportation methods.

Yesterday, we had news about ReCor Medical's renal denervation system getting positive votes from an FDA review panel. Today, we're talking about Medtronic's results, in which the panel said the risks of using the system outweigh the benefits. The Fast Five hosts explain what this means for Medtronic.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Masimo this week announced the launch of its Stork home baby monitoring system. Fast Five hosts Sean Whooley and Danielle Kirsh explain how the system works and how it fits in with the flagship products already with the company.

Home hemodialysis is on the rise. Fresenius Medical Care recently received FDA 510(k) clearance for its Versi HD with GuideMe software for its chronic home hemodialysis system. Find out when the technology will become available and how executives envision it for use in the home in today's episode.

Diabetes care devices are consistently innovating, and Welldoc's continuous glucose monitoring is having an exceptional month. Just a week after it received its tenth FDA clearance, Welldoc has received its 11th FDA clearance for its BlueStar digital diabetes management platform. Whooley details what makes this clearance unique and what the clearance allows the company to do.

Johnson & Johnson is placing more focus on its MedTech and Pharmaceutical division by splitting off its Kenvue consumer health business. The Fast Five hosts share the results of the split off and what executives are saying.

Renal denervation is a hot topic in medtech right now with varying opinions on its success. This week, an FDA panel voted unanimously in favor of the safety and efficacy of Recor Medical's Paradise ultrasound renal denervation system. Find out what data was included in the PMA submission and what executives are saying.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Medtronic's first-quarter results are in, and they were ahead of the consensus forecast on Wall Street. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the company's performance, what contributed to its growth and how each segment performed.

Wenzel Spine has received FDA clearance for expanded indications of its primaLOK SP system for spinal fusion procedures. Hear how the system works, what some of the features are and what doctors think about using the device.

Surgical robotics continue to innovate in medtech as Levita Magnetics won FDA clearance for its magnetic-assisted robot. Tune in to discover how the minimally invasive surgical platform works and how surgeons can benefit from using it.

Philips issued an urgent field safety notice for some of its imaging systems due to an issue that could lead to unintended radiation. Whooley shares the details of the issue, which systems are affected and what potential outcomes could arise if not addressed.

Personnel changes within the industry continue and today's episode covers a pretty big move – Zimmer Biomet's CEO is leaving the company to join another big player in medtech. Find out where he is going, as well as some of his accomplishments at ZB in today's episode. Also, hear who is taking over as CEO at Zimmer Biomet, as well as some other executive changes within ZB and 3M.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.